Press Releases
Splisense raises $28.5 million in series B to advance cystic fibrosis therapy
Splisense raises $28.5 million in series B to advance cystic fibrosis therapy By David Ho (/authors/47-david-ho) May 14, 2021 HONG KONG – Splisense
Menu